Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Feb 15, 2017; 9(2): 70-77
Published online Feb 15, 2017. doi: 10.4251/wjgo.v9.i2.70
Published online Feb 15, 2017. doi: 10.4251/wjgo.v9.i2.70
Patient demographics and primary disease (RCC) | |
Age | 63 yr (range: 44-80) |
Gender: male:female | 7:6 |
Nephrectomy: right:left | 6:7 |
Hepatic and pancreatic metastatic disease | |
Total cases | 14 |
Synchronous | 3 (2 liver, 1 pancreas) |
Metachronous | 11 |
Time between nephrectomy and diagnosis of metachronous disease | 57 mo (range: 4-292) |
Liver | 29 mo (range: 4-129) |
Pancreas | 80 mo (range: 10-292) |
Resection of metastases | |
Total cases | 14 |
Hepatic resections | 7 |
Right hepatectomy | 1 (with IVC resection) |
Non-anatomical hepatectomy | 6 (1 with en block diaphragmatic resection) |
Pancreatic resections: | 7 |
PD | 3 |
TP + S | 2 |
DP + S | 2 |
Post-operative complications | 5 |
Hepatic resections | 1 |
Chylous ascites | 1 (managed with parenteral nutrition) |
Pancreatic resections | 4 |
Pancreatic fistula | 2 (grade B) |
Fluid collection | 2 (managed with radiological-guided drainage and antibiotics) |
Bleeding | 2 (operative management) |
- Citation: Chatzizacharias NA, Rosich-Medina A, Dajani K, Harper S, Huguet E, Liau SS, Praseedom RK, Jah A. Surgical management of hepato-pancreatic metastasis from renal cell carcinoma. World J Gastrointest Oncol 2017; 9(2): 70-77
- URL: https://www.wjgnet.com/1948-5204/full/v9/i2/70.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i2.70